研究单位：[1]Department of Thoracic Surgery,Cancer Hospital of Sichuan Province
研究目的：
The main purpose of this randomized phase II trial is to evaluate the clinical feasibility and activity of administering adjuvant chemotherapy of pemetrexed/carboplatin compared with vinorelbine/carboplatin in patients with completely resected non-small cell lung cancer (NSCLC).
